Xconomy’s Digital Events →
Peter Lee, vice president, A.I. & Research, at Microsoft. Photo courtesy of Microsoft
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals